Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chromatin remodeling and leukemia: new therapeutic paradigms.

× No keyword cloud information.

28 in total

Review 1. Chromatin modification and disease.

Authors: C A Johnson
Journal: J Med Genet Date: 2000-12 Impact factor: 6.318

Review 2. Childhood leukaemia.

Authors: Mel Greaves
Journal: BMJ Date: 2002-02-02

3. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.

Authors: A Melnick; K F Ahmad; S Arai; A Polinger; H Ball; K L Borden; G W Carlile; G G Prive; J D Licht
Journal: Mol Cell Biol Date: 2000-09 Impact factor: 4.272

Review 4. Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.

Authors: Gerald V Denis
Journal: Discov Med Date: 2010-12 Impact factor: 2.970

Review 5. BET domain co-regulators in obesity, inflammation and cancer.

Authors: Anna C Belkina; Gerald V Denis
Journal: Nat Rev Cancer Date: 2012-06-22 Impact factor: 60.716

6. Ikaros induces quiescence and T-cell differentiation in a leukemia cell line.

Authors: Katie L Kathrein; Rachelle Lorenz; Angela Minniti Innes; Erin Griffiths; Susan Winandy
Journal: Mol Cell Biol Date: 2005-03 Impact factor: 4.272

7. Differentiation of NUT midline carcinoma by epigenomic reprogramming.

Authors: Brian E Schwartz; Matthias D Hofer; Madeleine E Lemieux; Daniel E Bauer; Michael J Cameron; Nathan H West; Elin S Agoston; Nicolas Reynoird; Saadi Khochbin; Tan A Ince; Amanda Christie; Katherine A Janeway; Sara O Vargas; Antonio R Perez-Atayde; Jon C Aster; Stephen E Sallan; Andrew L Kung; James E Bradner; Christopher A French
Journal: Cancer Res Date: 2011-03-29 Impact factor: 12.701

8. Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells.

Authors: Tim Thomas; Lynn M Corcoran; Raffi Gugasyan; Mathew P Dixon; Thomas Brodnicki; Stephen L Nutt; Donald Metcalf; Anne K Voss
Journal: Genes Dev Date: 2006-05-01 Impact factor: 11.361

9. Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia.

Authors: Olatoyosi M Odenike; Serhan Alkan; Dorie Sher; John E Godwin; Dezheng Huo; Stephen J Brandt; Margaret Green; Jingping Xie; Yanming Zhang; David H Vesole; Patrick Stiff; John Wright; Richard A Larson; Wendy Stock
Journal: Clin Cancer Res Date: 2008-11-01 Impact factor: 12.531

Review 10. Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.

Authors: Giuseppe Leone; Francesco D'Alò; Giuseppe Zardo; Maria Teresa Voso; Clara Nervi
Journal: Curr Med Chem Date: 2008 Impact factor: 4.530